Illness	Number of cases
Lipomatosis not elsewhere classified (E88.22)	84
Other disorders of skin and subcutaneous tissue not elsewhere classified - Excessive and redundant skin and subcutaneous tissue (L98.7)	69
Malignant neoplasm of breast (C50.9)	19
Postprocedural disorders of circulatory system not elsewhere classified (I97.82)	15
Hypertrophy of breast (N62)	14
Lymphedema not elsewhere classified (I89.01)	13
Complications of other internal prosthetic devices implants and grafts (T85.82)	13
Malignant neoplasm of breast (C50.1)	11
Postprocedural disorders of circulatory system not elsewhere classified (I97.85)	10
Hypertrophic disorders of skin - Hypertrophic scar (L91.0)	8

Top 10 treatments

Treatment	Number
Operation to tighten the skin or subcutaneous tissues and remove fatty tissue, apart from the face (5-911.1e)	72
Other operations on the lymphatic system (5-408.0)	43
Operation to tighten the skin or subcutaneous tissues and remove fatty tissue, apart from the face (5-911.0b)	40
Operation to tighten the skin or subcutaneous tissues and remove fatty tissue, apart from the face (5-911.1f)	29
Reconstructive operation on the breast with skin and muscle grafting (transplantation) (5-885.9)	26
Simple surgical closure of the skin or the subcutaneous tissues after injuries, e.g. with a suture (5-900.0b)	26
Surgical breast reduction (5-884.2)	19
Extensive surgical removal of diseased tissue from the skin or subcutaneous tissues (5-895.2b)	18
Operation to tighten the skin or subcutaneous tissues and remove fatty tissue, apart from the face (5-911.17)	16
Other operations on the breast (5-889.1)	15

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 1900

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
47	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
46	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
46	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities	APL der Heinrich-Heine-Universität Düsseldorf
Student training (clinical traineeship / internship year)
Doctoral supervision